Ep Evaluator 12 -

SVT diagnoses (AVNRT, AVRT, AT) rely on subtle differences in VA intervals, atrial activation sequence, and response to pacing. EP Evaluator 12’s zoom and overlay capabilities allow the user to superimpose beats from different pacing maneuvers (e.g., entrainment from the RV apex vs. base) to confirm a diagnosis with high confidence.

To understand the true value of EP Evaluator 12, consider these common scenarios:

In scar-related VT or accessory pathway localization, pace mapping is essential. The software compares the paced 12-lead ECG morphology with the clinical tachycardia morphology using correlation algorithms (e.g., Pearson’s coefficient). A score of >0.95 suggests the pacing site is close to the arrhythmia origin. EP Evaluator 12 displays these comparisons side-by-side with beat-by-beat alignment, facilitating precise ablation targeting. ep evaluator 12

How does EP Evaluator 12 stack up against other options like GE’s CardioLab or the built-in review tools from mapping systems?

EP Evaluator 12 wins decisively in mixed-lab environments or any setting that prioritizes long-term data continuity over vendor lock-in.

In the high-stakes world of clinical electrophysiology (EP), precision is not just a goal—it is a prerequisite for patient safety. Cardiologists and EP labs generate terabytes of complex data daily, from intracardiac electrograms to 3D activation maps. Making sense of this data requires more than just a keen eye; it requires robust, specialized software. For over two decades, one name has stood out in the industry: EP Evaluator. With the release of EP Evaluator 12, the platform has raised the bar for what clinicians can expect from post-processing, archiving, and reporting. However, the core version of EP Evaluator 12

The next frontier for EP analysis is machine learning. Early research shows that AI models can detect conduction gaps after AF ablation or predict VT circuits from baseline EGMs. EP Evaluator’s architecture is positioned to integrate such algorithms. Philips has indicated that future updates may include:

However, the core version of EP Evaluator 12 today remains a robust diagnostic tool, with AI as an assistive layer, not a replacement for physician judgment.

EP Evaluator 12 is a dedicated software platform developed by EP Solutions SA (now part of the Philips portfolio following strategic acquisitions) for the comprehensive analysis, storage, and reporting of invasive electrophysiology studies. The "12" in its name signifies its ability to handle up to 12 simultaneous intracardiac electrogram (EGM) channels—a critical feature for complex arrhythmia mapping, including atrial fibrillation (AF), ventricular tachycardia (VT), and supraventricular tachycardia (SVT).

Unlike real-time recording systems used in the EP lab (such as the Prucka CardioLab or GE MacLab), EP Evaluator 12 is an offline analysis workstation. This means it allows physicians to review and meticulously measure previously recorded studies with advanced tools that are not feasible during live patient procedures due to time constraints.